Phase I clinical and pharmacokinetic study of PM01183 (a tetrahydroisoquinoline, Lurbinectedin) in combination with gemcitabine in patients with advanced solid tumors
Paz-Ares, Luis, Forster, Martin, Boni, Valentina, Szyldergemajn, Sergio, Corral, Jesús, Turnbull, Samantha, Cubillo, Antonio, Teruel, Carlos Fernandez, Calderero, Iker López, Siguero, Mariano, Bohan,Volume:
35
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-016-0410-3
Date:
April, 2017
File:
PDF, 329 KB
english, 2017